Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Inscopix Launches a Cutting-Edge “All-Optical” Brain Mapping Platform to Advance the Understanding of Cognition, Behavior, and Brain Disorders

Inscopix
Posted on: 15 Nov 16

Inscopix, the neuroscience company that transformed real-time brain mapping with its miniature microscope invention, unveiled a new research product, nVoke, at the Society for Neuroscience Annual Meeting in San Diego today. nVoke combines two powerful neuroscience techniques, calcium imaging and optogenetics, into a single groundbreaking “all-optical” platform for precise measurement and modulation of brain activity patterns with light. These patterns are thought to underlie our thoughts, emotions, actions, sensations, and behavior.

Speaking at the launch, UCSF Neuroscience Program Director, Anatol Kreitzer, Ph.D., said, “Simultaneously recording and stimulating defined populations of neurons in the brain during natural behavior has been an aspiration and a long-standing challenge in the field of neuroscience. As an early-tester of nVoke, it has been exciting to experience first-hand its transformative potential for elucidating how neural circuit activity and plasticity shapes behavior, both in health and disease.”

nVoke empowers brain researchers with unprecedented technological capability in testing the causal relationship between electrical activity in specific populations of nerve cells and behavior, and in deciphering the functional interactions between groups of neurons within and across brain regions. nVoke represents a major step forward in the development of a new generation of precise, closed-loop “all-optical” devices for understanding and possibly even correcting the pathophysiology underlying psychiatric and neurological disorders such as depression, Parkinson's disease and epilepsy.

nVoke builds upon the same miniature microscope platform that formed the core of Inscopix’s inaugural brain mapping product, nVista, for invivo calcium imaging. However, integrating calcium imaging and optogenetics into a single system posed a difficult technological challenge, in part due to the independent evolution of these relatively new technologies in the past decade. nVoke is the culmination of a 2-year concerted R&D effort by a transdisciplinary team of Inscopix engineers, physicists, and neuroscientists working in close partnership with leading neuroscience investigators across the globe.

Inscopix CEO and founder, Kunal Ghosh, Ph.D., said, “At Inscopix, we very much view ourselves as an integral part of Team Science. nVoke’s promise for bringing tour-de-force circuit-level investigations of brain function and behavior within reach of neuroscientists is, of course, hard to overstate. However, the unprecedented level of collaboration between the neuroscience research community and Inscopix that led to its development is equally significant. nVoke is truly emblematic of the game-changing technological innovations and scientific breakthroughs that are catalyzed when all of us in the neuroscience ecosystem work together in a cooperative and purposeful way.”

nVoke will be initially disseminated to the neuroscience community through an early access program. To learn more or sign up for early access, please visit https://www.inscopix.com/products/nvoke

About Inscopix

Inscopix is a discovery phase neuroscience company in Silicon Valley that is focused on advancing the mechanistic understanding of the brain at the level of neural circuits and networks. Inscopix develops miniaturized real-time brain mapping platforms that pave the way for incisive new insights into healthy brain function and for next-generation diagnostics, treatments and therapeutics for brain disorders. Inscopix was recognized as a private-sector partner of the Presidential BRAIN Initiative in 2014 and by the World Economic Forum as a Technology Pioneer 2015.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161115005572/en/

Business Wire
www.businesswire.com

Last updated on: 15/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.